After adjusting for maternal confounders, children born to mothers who continued to use attention-deficit/hyperactivity disorder (ADHD) medications during pregnancy were no more likely to have neurodevelopmental disorders than those whose mothers discontinued use, according to a population-based cohort study published in Molecular Psychiatry.
Source: JAMA Online First